Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

BioNTech Reports Topline Data From Ongoing Phase 2 Clinical Trial For mRNA Immunotherapy Candidate BNT111 For Advanced Melanoma; Trial Met Its Primary Efficacy Outcome Measure

Author: Benzinga Newsdesk | July 30, 2024 06:47am

The Phase 2 trial will continue as planned to further assess the secondary endpoints, which were not mature at the time of the primary analysis.

Posted In: BNTX